SCHEMBL361764

SCHEMBL361764

c1ccc2cc3occc3cc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.50
MAOA P21397 2/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
NFKB1 P19838 1/20 0.50
ACHE P22303 1/20 0.50
CYP2C19 P33261 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PTPN1 P18031 1/20 0.43
CTNNB1 P35222 1/20 0.41
WNT3A P56704 1/20 0.41
DYRK1A Q13627 3/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39
CDK9 P50750 1/20 0.38
EPM2A O95278 1/20 0.38
PTPRC P08575 1/20 0.38
PTPN6 P29350 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14232041 0.98 CYP2A6 (0.48) CYP2A6MAOAKDM4ECYP3A4CYP2D6
Acetonitrile SCHEMBL28277435 0.88 CYP2A6 (0.47) CYP2A6MAOAKDM4ECYP3A4CYP2D6
SCHEMBL17086865 0.87 CYP2A6 (0.56) CYP2A6MAOAKDM4ECYP3A4CYP2D6
SCHEMBL17086913 0.87 CYP2A6 (0.56) CYP2A6MAOAKDM4ECYP3A4CYP2D6
SCHEMBL17086866 0.87 CYP2A6 (0.56) CYP2A6MAOAKDM4ECYP3A4CYP2D6
SCHEMBL17086914 0.87 CYP2A6 (0.56) CYP2A6MAOAKDM4ECYP3A4CYP2D6
SCHEMBL2149910 0.87 CYP2A6 (0.54) CYP2A6MAOAKDM4ECYP3A4CYP2D6
SCHEMBL14762862 0.85 HSD17B10 (0.41) CYP2A6MAOAKDM4ECYP3A4CYP2D6
Anthracene SCHEMBL25290181 0.85 CYP2A6 (0.42) CYP2A6MAOAKDM4ECYP3A4CYP2D6
SCHEMBL4416833 0.84 CYP2A6 (0.64) CYP2A6MAOAKDM4ECYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107721958-A The new compound and composition of target on cancer stem cell 北京强新生物科技有限公司 2018-02-23 CN claimed
CN-107311969-A The new compound and composition of target on cancer stem cell 北京强新生物科技有限公司 2017-11-03 CN claimed
CN-106410050-A Organic light emitting pixel and organic light emitting display device including the same 三星显示有限公司 2017-02-15 CN claimed
CN-105037332-A COMPOUND, LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LAB 2015-11-11 CN claimed
CN-103402993-A Novel esters of 4, 9-dihydroxy-naphtho [2,3-b ] furans for the treatment of diseases ZHOUSHAN HAIZHONGZHOU XINSHENG PHARMACEUTICALS CO LTD 2013-11-20 CN claimed
US-20100209431-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME NATIONAL UNIVERSITY OF SINGAPORE 2010-08-19 US claimed
EP-2147005-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME National University of Singapore (SG) 2010-01-27 EP claimed
WO-2008127197-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME NATIONAL UNIVERSITY OF SINGAPORE (SG) 2008-10-23 WO claimed
US-6818772-B2 DIETETICS, SLEEP DISORDERS, EATING DISORDERS, SEXUAL DISORDERS, CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS ABBOTT LABORATORIES 2004-11-16 US claimed
CN-120136832-A Naphtho [2,3-b ] furan-5, 8-dione compound with antioxidant activity, and preparation method and application thereof 云南民族大学 2025-06-13 CN disclosed
WO-2025104569-A1 METHOD FOR PRODUCING LIGHT-EMITTING DEVICE 株式会社半導体エネルギー研究所 2025-05-22 WO disclosed
WO-2025032476-A1 ORGANIC SEMICONDUCTOR DEVICE, LIGHT-EMITTING DEVICE, LIGHT-RECEIVING DEVICE, AND DISPLAY APPARATUS 株式会社半導体エネルギー研究所 2025-02-13 WO disclosed
WO-2024261608-A1 DISPLAY APPARATUS 株式会社半導体エネルギー研究所 2024-12-26 WO disclosed
WO-2024241140-A1 METHOD FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE, METHOD FOR MANUFACTURING LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING PHOTOSENSOR 株式会社半導体エネルギー研究所 2024-11-28 WO disclosed
EP-1077969-A1 BENZOTHIOPHENES, BENZOFURANS, AND INDOLES USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 EP disclosed
EP-1077968-A1 NAPHTHO[2,3-B]HETEROAR-4-YL DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 2001-02-28 EP disclosed
US-6121271-A ANTIDIABETIC AGENTS AMERICAN HOME PRODUCTS CORPORATION (US) 2000-09-19 US disclosed
WO-1999061435-A1 BENZOTHIOPHENES, BENZOFURANS, AND INDOLES USEFUL IN THE TREATMENT OF INSULIN RESISTANCE AND HYPERGLYCEMIA AMERICAN HOME PRODUCTS CORPORATION (US) 1999-12-02 WO disclosed
WO-1999058522-A1 NAPHTHO[2,3-B]HETEROAR-4-YL DERIVATIVES AMERICAN HOME PRODUCTS CORPORATION (US) 1999-11-18 WO disclosed
EP-0175450-B1 AN INTERPHENYLENE-CARBACYCLIN COMPOUND THE UPJOHN COMPANY (US) 1989-03-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100209431-A1 METAL TRIANGULO COMPOUND AND METHODS OF USING THE SAME CASP3, BAX, CASP7 CYP2A6 1359/4885MAOA 3480/4885KDM4E 3090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.